Free Access
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 33 - 38
Published online 07 November 2018
  1. Pandiani C, Beranger GE, Leclerc J, et al. Focus on cutaneous and uveal melanoma specificities. Genes Dev 2017 ; 31 : 724–743. [CrossRef] [PubMed] [Google Scholar]
  2. Millet A, Martin AR, Ronco C, et al. Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges. Med Res Rev 2017 ; 37 : 98–148. [CrossRef] [PubMed] [Google Scholar]
  3. Lim SY, Menzies AM, Rizos H. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma. Cancer 2017 ; 123 : 2118–2129. [CrossRef] [PubMed] [Google Scholar]
  4. Volpe VO, Klufas DM, Hegde U, Grant-Kels JM. The new paradigm of systemic therapies for metastatic melanoma. J Am Acad Dermatol 2017 ; 77 : 356–368. [CrossRef] [PubMed] [Google Scholar]
  5. Shanmugam MK, Lee JH, Chai EZ, et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin Cancer Biol 2016 ; 40–41 : 35–47. [CrossRef] [PubMed] [Google Scholar]
  6. Xiao Z, Morris-Natschke SL, Lee KH. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Med Res Rev 2016 ; 36 : 32–91. [CrossRef] [PubMed] [Google Scholar]
  7. Fangjun L, Zhijia Y. Tumor suppressive roles of eugenol in human lung cancer cells. Thorac Cancer 2017. [Google Scholar]
  8. Ghavre M, Froese J, Pour M, Hudlicky T. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives. Angew Chem Int Ed Engl 2016 ; 55 : 5642–5691. [CrossRef] [PubMed] [Google Scholar]
  9. Kang J, Zhang Y, Cao X, et al. Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. Int Immunopharmacol 2012 ; 12 : 249–256. [CrossRef] [PubMed] [Google Scholar]
  10. Guo Y, Wang Y, Cao L, et al. A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus. Antimicrob Agents Chemother 2016 ; 60 : 913–924. [CrossRef] [PubMed] [Google Scholar]
  11. Roy M, Liang L, Xiao X, et al. Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma. Theranostics 2016 ; 6 : 2209–2224. [CrossRef] [PubMed] [Google Scholar]
  12. Hu M, Peng S, He Y, et al. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. Oncotarget 2015 ; 6 : 15348–15361. [PubMed] [Google Scholar]
  13. Yu H, Qiu Y, Pang X, et al. Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol Cancer Ther 2017. [Google Scholar]
  14. Subramaniam S, Sundarasekar J, Sahgal G, Murugaiyah V. Comparative analysis of lycorine in wild plant and callus culture samples of Hymenocallis littoralis by HPLC-UV method. ScientificWorldJournal 2014 ; 2014 : 408306. [CrossRef] [PubMed] [Google Scholar]
  15. Nair JJ, van Staden J, Bastida J. Apoptosis-Inducing Effects of Amaryllidaceae Alkaloids. Curr Med Chem 2016 ; 23 : 161–185. [CrossRef] [PubMed] [Google Scholar]
  16. Nair JJ, van Staden J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat Prod Commun 2014 ; 9 : 1193–1210. [Google Scholar]
  17. Wang J, Xu J, Xing G. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway. Acta Biochim Biophys Sin (Shanghai) 2017 ; 49 : 771–779. [CrossRef] [PubMed] [Google Scholar]
  18. Wang C, Wang Q, Li X, et al. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade. Biochem Biophys Res Commun 2017 ; 483 : 197–202. [CrossRef] [Google Scholar]
  19. Zhao D, Han W, Liu X, et al. MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2. Thorac Cancer 2017 ; 8 : 304–311. [CrossRef] [PubMed] [Google Scholar]
  20. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
  21. Park S, Chapuis N, Tamburini J, et al. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica 2010 ; 95 : 819–828. [CrossRef] [PubMed] [Google Scholar]
  22. Yoshikawa Y, Takano O, Kato I, et al. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway. Cancer Lett 2017 ; 410 : 82–91. [CrossRef] [Google Scholar]
  23. Yin K, Wang L, Zhang X, et al. Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway. Oncotarget 2017 ; 8 : 51177–51189. [PubMed] [Google Scholar]
  24. Hu B, Lv X, Gao F, et al. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway. OncoTargets and therapy 2017 ; 10 : 4379–4391. [CrossRef] [PubMed] [Google Scholar]
  25. Wei Y, Wu S, Xu W, et al. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP. Thorac Cancer 2017 ; 8 : 26–32. [CrossRef] [PubMed] [Google Scholar]
  26. Basho RK, Gilcrease M, Murthy RK, et al. Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab. JAMA Oncol 2017 ; 3 : 509–515. [CrossRef] [PubMed] [Google Scholar]
  27. Calero R, Morchon E, Martinez-Argudo I, Serrano R. Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma. Cancer Lett 2017 ; 406 : 1–11. [CrossRef] [Google Scholar]
  28. Choi EO, Cho EJ, Jeong JW, et al. Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway. Biomol Ther (Seoul) 2017 ; 25 : 213–221. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.